March 25 (Reuters) - Mesoblast Ltd MSB.AX :
* CO'S LICENSEE IN JAPAN, JCR PHARMACEUTICALS CO. LTD., HAS FILED TO EXTEND MARKETING APPROVAL OF TEMCELL HS INJECTION
March 25 (Reuters) - Mesoblast Ltd MSB.AX :
* CO'S LICENSEE IN JAPAN, JCR PHARMACEUTICALS CO. LTD., HAS FILED TO EXTEND MARKETING APPROVAL OF TEMCELL HS INJECTION